Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

SELL
$209.01 - $232.56 $63,539 - $70,698
-304 Reduced 8.05%
3,474 $758,000
Q4 2023

Feb 05, 2024

BUY
$197.69 - $227.29 $115,253 - $132,510
583 Added 18.25%
3,778 $858,000
Q3 2023

Nov 13, 2023

SELL
$201.05 - $221.7 $12,666 - $13,967
-63 Reduced 1.93%
3,195 $642,000
Q2 2023

Aug 10, 2023

SELL
$211.93 - $241.33 $50,651 - $57,677
-239 Reduced 6.83%
3,258 $786,000
Q1 2023

May 04, 2023

BUY
$213.32 - $257.83 $62,289 - $75,286
292 Added 9.11%
3,497 $802,000
Q4 2022

Feb 10, 2023

BUY
$203.72 - $248.97 $25,872 - $31,619
127 Added 4.13%
3,205 $754,000
Q3 2022

Nov 09, 2022

BUY
$204.81 - $262.19 $43,214 - $55,322
211 Added 7.36%
3,078 $630,000
Q2 2022

Aug 16, 2022

SELL
$213.86 - $277.87 $89,393 - $116,149
-418 Reduced 12.72%
2,867 $671,000
Q1 2022

May 10, 2022

BUY
$259.82 - $298.18 $90,157 - $103,468
347 Added 11.81%
3,285 $866,000
Q4 2021

Feb 03, 2022

BUY
$271.6 - $314.21 $45,357 - $52,473
167 Added 6.03%
2,938 $923,000
Q3 2021

Nov 04, 2021

SELL
$274.82 - $308.34 $9,618 - $10,791
-35 Reduced 1.25%
2,771 $780,000
Q2 2021

Aug 05, 2021

SELL
$251.87 - $278.14 $64,982 - $71,760
-258 Reduced 8.42%
2,806 $774,000
Q1 2021

Jun 02, 2021

SELL
$204.88 - $255.03 $4,302 - $5,355
-21 Reduced 0.68%
3,064 $781,000
Q4 2020

Feb 10, 2021

BUY
$186.91 - $214.42 $14,578 - $16,724
78 Added 2.59%
3,085 $628,000
Q3 2020

Nov 05, 2020

SELL
$167.03 - $201.3 $668 - $805
-4 Reduced 0.13%
3,007 $566,000
Q2 2020

Aug 05, 2020

SELL
$113.31 - $182.44 $27,421 - $44,150
-242 Reduced 7.44%
3,011 $500,000
Q1 2020

May 06, 2020

BUY
$104.32 - $195.28 $73,128 - $136,891
701 Added 27.47%
3,253 $411,000
Q4 2019

Feb 07, 2020

SELL
$163.48 - $173.61 $4,577 - $4,861
-28 Reduced 1.09%
2,552 $432,000
Q3 2019

Nov 12, 2019

SELL
$159.77 - $178.1 $10,544 - $11,754
-66 Reduced 2.49%
2,580 $433,000
Q2 2019

Aug 12, 2019

SELL
$144.16 - $172.9 $51,176 - $61,379
-355 Reduced 11.83%
2,646 $457,000
Q1 2019

May 10, 2019

SELL
$123.7 - $156.3 $66,921 - $84,558
-541 Reduced 15.27%
3,001 $459,000
Q4 2018

Feb 06, 2019

SELL
$120.82 - $174.09 $93,152 - $134,223
-771 Reduced 17.88%
3,542 $448,000
Q3 2018

Nov 09, 2018

SELL
$167.67 - $188.27 $8,718 - $9,790
-52 Reduced 1.19%
4,313 $749,000
Q2 2018

Aug 08, 2018

SELL
$160.33 - $189.41 $28,859 - $34,093
-180 Reduced 3.96%
4,365 $784,000
Q1 2018

May 03, 2018

BUY
$161.53 - $178.11 $38,928 - $42,924
241 Added 5.6%
4,545 $735,000
Q4 2017

Feb 08, 2018

BUY
$147.99 - $163.95 $14,946 - $16,558
101 Added 2.4%
4,304 $686,000
Q3 2017

Nov 06, 2017

BUY
$149.47 - $160.56 $628,222 - $674,833
4,203
4,203 $635,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.9B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Intrust Bank Na Portfolio

Follow Intrust Bank Na and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intrust Bank Na, based on Form 13F filings with the SEC.

News

Stay updated on Intrust Bank Na with notifications on news.